Master of Science [M.Sc] [Nanomedicine] From Swansea University

Academic Eligibility:

• Students should have completed a bachelor’s degree with:
  • 55%; or
  • CGPA 6.1 (10 point system); or
  • CGPA 4.5 (7 point system); or
  • CGPA 2.67 (4 point system)
• Students should hold a 2:2 in a relevant subject such as biochemistry, biology, genetics, physics, pharmacology, medical engineering, pharmacy.
• Significant relevant experience may be accepted in lieu of a degree.

Indian Student Eligibility:

• Completed a 4-year UG degree with first class in a relevant field from a recognized institution.
• Students with 75% marks in English in 12th from Senior School Certificate Examination (SSCE) from (CBSE) or Indian Certificate of Secondary Education (ICSE) from (CISCE); or Indian School Certificate (ISC) from (CISCE) can fulfill ELP requirement.
• Students must show that they have also studied for their Bachelor's degree in English.

Along with the minimum eligibility requirements, international students hailing from non-English speaking countries need to prove English proficiency through IELTS/TOEFL/any equivalent test to get admission to this program.

A postgraduate degree is designed to equip our graduates with transferable skills that are highly valued in the workplace. College research-led ethos ensures that students explore the frontiers of scientific knowledge, and the intensive practical components provide rigorous training in cutting edge technical skills that are used in the modern biosciences (scientific or clinical research career in the fields of nanomedicine and advanced therapeutics) while working in areas of world-leading expertise within the School.

The nanomedicine course appeals to all sectors of life sciences. The college has students who have left the course and gone onto industry, academia (PhDs), and professional vocations.  Most do stay on in academia; some do a Ph.D. in a more specific field related to nanomedicine, others go on to Graduate Entry Medicine.  Some have gone onto industry, with a range of biopharmaceutical to biotechnology companies in the fields of drug/technology testing and development.